Skip to content

Comparison of Ascorbic Acid and Grape Seed Extract in Oxidative Stress Induced by on Pump Heart Surgery

Effect of Ascorbic Acid and Grape Seed Extract Vitis Vinifera L. in Oxidative Stress Induced by on Pump Coronary Artery by Pass Grafting Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00839085
Enrollment
72
Registered
2009-02-09
Start date
2008-11-30
Completion date
2009-03-31
Last updated
2009-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CABG-Induced Oxidative Stress

Keywords

CABG, on pump, Grape seed extract, Vit C, Oxidative stress

Brief summary

Study aimed to compare the effect of grape seed extract and ascorbic acid in oxidative stress induced by on pump coronary artery by pass grafting surgery.

Detailed description

This study aimed to compare the effect of grape seed extract and ascorbic acid in oxidative stress induced by on pump coronary artery by pass grafting surgery. There are three groups in the study. 75 candidate of coronary artery by pass grafting surgery were assigned random allocation on the groups (25 in each group). 1. Control 2. GSE (100 mg/6h - PO, 24h before surgery) 3. Vit C (25 mg/kg in pump circulation during surgery)

Interventions

DRUGGSE

grape seed extract (100 mg/6h), PO

DRUGVit C (Ascorbic Acid)

Vit C 25 mg/ kg

Sponsors

Tabriz University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Candidates for elective CABG surgery with pump for first time * 3VD

Exclusion criteria

* High risk patients * Those who need another heart surgery beside CABG * Urgent patients * Diabetics * Ischemic time more than 120 min

Design outcomes

Primary

MeasureTime frame
LVEFBefore and after CABG

Secondary

MeasureTime frame
Total Antioxidant Capacity (TAC)Before ischemia, after ischemia, after reperfusion
MDABefore, middle and after CABG
GTXBefore ischemia, after ischemia, after reperfusion
SODBefore ischemia, after ischemia, after reperfusion

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026